Stocks / NASDAQ / TCR2 Therapeutics Inc.

TCR2 Therapeutics Inc.

Our Opinion

TCR2 Therapeutics Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“TC-210 has shown robust anti-tumor activity in cellular assays and animal models of malignant pleural/peritoneal mesothelioma, lung and ovarian cancers.” (page 13) Read the full document

Company Description

Company Website: